Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Making Proteins To Fight Cancer

13.01.2006


An approach to treating intestine cancer is being developed by Russian researchers from the Bioengineering Centre, Russian Academy of Sciences, under Anna Prokhorchuk’s guidance jointly with American colleagues sponsored by the international CRDF foundation and the Federal Agency for Science and Innovation (Rosnauka).



Any cancerous disease changes the genetic landscape – some genes are suppressed, others get activated, which results in tumour growth, the formation of metastases, and cancer spreads beyond immune system control. The universal mechanism which regulates genes’ activity is DNA methylation, where a methyl group is joined to a certain section of a molecule. Special methyl-DNA binding proteins come into action, bound with a section of the methylated DNA and this suppresses gene activity. The researchers are interested in one of such proteins named Kaiso. They assume that this protein plays an important role in the intestine cancer development, and it can be used for diagnostics and treatment.

First, the researchers measured the level of expression of the Kaiso protein gene in intestinal tumours in mice and in human patients. The level of expression turned out to be dozens of times higher than that in healthy organs and tissues. ‘Kaiso-zero’ mice were then used which were found to be resistant to cancer. The same resistance to cancer was acquired by mice whose DNA methylation had been suppressed by other methods.


As the Kaiso protein content in the majority of human tumours is much higher than that in healthy tissues, it can be potentially used for early detection of cancer. Contemporary molecular methods allow to analyze expression of dozens of genes in the cancerous growth tissues and to compare the obtained picture with the “gene portrait” of normal cells. Certainly, the Kaiso gene is not the only one that can be used for such diagnosticums. The tumour represents a very heterogeneous and rather dynamic system, which requires knowledge of almost the entire “genetic portrait” of 28,000 genes.

It is thought that there are other between 10 and 30 key genes which can also serve as markers of tumour characteristics. This will save resources and time, relieving the necessity of analyzing the entire multithousand genome.

In cancer therapy, chimeric Kaiso protein could be created. The ordinary Kaiso protein (via DNA methylated binding) inhibits the work of cancer suppressor genes. However, it is possible, using the same properties of the protein, to make it not suppress, but reinforce the work of these genes. This is what the researchers are striving to achieve. “Although, there are hidden pitfalls here,” explains Anna Prokhorchuk, project manager. “It is necessary to make chimeric Kaiso work only to activate cancer suppressor genes, not the other methylated DNA sequences. This is what we are working at in the Bioengineering Centre jointly with American colleagues.” The ultimate aim of the investigation is to scrutinize the possibility for using Kaiso protein as a target for directional anticancer therapy.

Sergey Komarov | alfa
Further information:
http://www.informnauka.ru

More articles from Life Sciences:

nachricht Cryo-electron microscopy achieves unprecedented resolution using new computational methods
24.03.2017 | DOE/Lawrence Berkeley National Laboratory

nachricht How cheetahs stay fit and healthy
24.03.2017 | Forschungsverbund Berlin e.V.

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

Im Focus: Researchers Imitate Molecular Crowding in Cells

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Argon is not the 'dope' for metallic hydrogen

24.03.2017 | Materials Sciences

Astronomers find unexpected, dust-obscured star formation in distant galaxy

24.03.2017 | Physics and Astronomy

Gravitational wave kicks monster black hole out of galactic core

24.03.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>